Needs assessments for 3 CME programs: diabetes and cardiovascular disease, thyroid and parathyroid disease, and osteoporosis, prepared December 2010. [BAC, writer]
Kendall DM, Chilton R, Einhorn D. A fresh look at hormonal approaches to type 2 diabetes mellitus, weight, and cardiometabolic risk: the role of gut hormones. Endocrine Practice 2010;16(2):33-38. [BAC and FR, writers]
Kaplan LM, Pinkney J. Point-counterpoint: debating gastrointestinal metabolic and bariatric surgery in endocrine practice. Endocrine Practice 2010;16(2):39-42. [BAC and FR, writers]
Ismail-Beigi F, Hirsch I, Raskin P. Insulin for inpatients: intensive control outside the intensive care unit. Endocrine Practice 2010;16(2):43-47. [BAC and FR, collaborating writers]
Poster for the ICE meeting about treatment of primary IGF-1 deficiency, prepared October 2008. [BAC, collaborating writer]
Newsletter for sales representatives explaining the epidemiology, pathophysiology, diagnosis, and treatment of diabetes mellitus, prepared June 2008. [FR, writer]
"Endocrine and Metabolic Disorders" (teaching slides for geriatrics residents). American Geriatrics Society, http://teachingslides.americangeriatrics.org, May 2007. [BAC and FR, writers]
Review of insulin therapy for type 2 diabetes, prepared April 2007. [FR, collaborating writer]
Review about the safety of testosterone replacement therapy with regard to prostate cancer, prepared April 2006. [BAC and FR, collaborating writers]
Grundy SM. A constellation of complications: the metabolic syndrome. Clin Cornerstone. 2005; 7(2/3):36-45. [FR, collaborating writer]
Chin-Hong PV. Infections in patients with diabetes mellitus: importance of early recognition, treatment, and prevention. Adv Stud Med. 2006;6:71-81. [FR, collaborating writer]
Review about the diagnosis and management of thyroid disorders, prepared for Advanced Studies in Medicine, April 2005. [FR, collaborating writer]
Six-month contract to conduct quantitative message gap analyses on hyperparathyroidism secondary to end-stage renal disease (2004-2005). [BAC, researcher]
Bylined news reports distributed on Reuters Health wire service [FR, writer]:
Smoking increases risk of diabetic nephropathy despite ACE inhibition, 1-28-2003.
Interference with fat metabolism in the brain causes weight loss in rats, 12-12-2002.
Microalbuminuria, type 2 diabetes, CVD develop together over decades, 6-21-2002.
Addition of IGF-1 improves control in adolescent diabetics without increasing adiposity, 7-6-1999.
Viagra safe, efficacious for diabetics, 6-17-1999.
Growth hormone boosts height in short children, 2-17-1999.
Orlistat plus diet produces modest weight loss, improves CVD risk factors, 1-20-1999.
Parathyroid hormone prevents bone loss, 9-22-1998.
Cocaine tied to diabetic ketoacidosis, 9-15-1998.
Low-dose combination oral contraceptives safe after gestational diabetes, 8-12-1998.
Leptin concentrations vary with zinc status, 7-6-1998.
Leptin production regulated by hexosamine biosynthetic pathway, 6-18-1998.
No link between dexfenfluramine, pulmonary hypertension in rats, 5-13-1998.